Cargando…

Epstein–Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease

Infection with EBV has been associated with various inflammatory disorders including inflammatory bowel diseases (IBD). Contribution of this virus to intestinal disease processes has not been assessed. We previously detected that EBV DNA triggers proinflammatory responses via the activation of endos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andari, Sirine, Hussein, Hadi, Fadlallah, Sukayna, Jurjus, Abdo R., Shirinian, Margret, Hashash, Jana G., Rahal, Elias A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310145/ https://www.ncbi.nlm.nih.gov/pubmed/34210024 http://dx.doi.org/10.3390/v13071272

Ejemplares similares

Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model
por: Fadlallah, Sukayna, et al.
Publicado: (2021)

The interplay between Epstein-Barr virus DNA and gut microbiota in the development of arthritis in a mouse model
por: Fadlallah, Sukayna, et al.
Publicado: (2023)

Drosophila melanogaster as a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases
por: Madi, Joelle R., et al.
Publicado: (2021)

Epstein-Barr Virus DNA Enhances Diptericin Expression and Increases Hemocyte Numbers in Drosophila melanogaster via the Immune Deficiency Pathway
por: Sherri, Nour, et al.
Publicado: (2018)

Spontaneous and transgenic rodent models of inflammatory bowel disease
por: Prattis, Susan, et al.
Publicado: (2015)

Editorial: The microbial modulation of autoimmune processes and proinflammatory pathways
por: Rahal, Elias A., et al.
Publicado: (2022)

Acute Gastrointestinal Hemorrhage due to Epstein-Barr Virus Colitis
por: Denicola, Richard P., et al.
Publicado: (2019)

Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype
por: Rahal, Elias A., et al.
Publicado: (2015)

Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disease and colorectal cancer
por: El-Harakeh, Mohammad, et al.
Publicado: (2022)

Chronic active Epstein-Barr exacerbated by COVID-19 co-infection
por: Villafuerte, David B, et al.
Publicado: (2022)

Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9
por: Salloum, Noor, et al.
Publicado: (2018)

Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis
por: Chan, Patrick P.Y., et al.
Publicado: (2023)

Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease
por: Zhang, Hui, et al.
Publicado: (2022)

Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice
por: Al Kattar, Sahar, et al.
Publicado: (2020)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines
por: Kotaki, Ryutaro, et al.
Publicado: (2020)

Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
por: Jallad, Mary-Ann N., et al.
Publicado: (2020)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Rituximab-Induced Remission in Epstein−Barr Virus−Associated Glomerulonephritis
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2020)

Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area
por: Xu, Shu, et al.
Publicado: (2020)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Clinical features of Epstein–Barr virus in the intestinal mucosa and blood of patients with inflammatory bowel disease
por: Zhou, Jin-Qiu, et al.
Publicado: (2020)

Epstein–Barr virus seroprevalence and viral load at disease onset in children with inflammatory bowel disease
por: Kornitzer, Gaël, et al.
Publicado: (2022)

Alternative Therapy for Epstein-Barr Virus Related Hemophagocytic Lymphohistiocytosis
por: Al Asad, Omar, et al.
Publicado: (2015)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

An Epstein-Barr virus-associated superantigen
Publicado: (1996)

Macular Amyloidosis and Epstein-Barr Virus
por: Nahidi, Yalda, et al.
Publicado: (2016)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Epstein-Barr Virus Neurologic Complications
por: Millichap, J. Gordon
Publicado: (2015)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)

Epstein-Barr Virus in Gastric Carcinoma
por: Nishikawa, Jun, et al.
Publicado: (2014)

Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
por: Marsh, Rebecca A.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vn7hfehhhsqs9s6jogf4e0elhc